FeesSafety
Pluang+

Six major dividend stocks pay more than they earn, risking future cuts and investor losses.

Market News
07 Oct 2026, 14:15 WIB
24/7 Wall Street
View Source
Bearish
Six major dividend stocks pay more than they earn, risking future cuts and investor losses.

Six well-known dividend-paying companies, including Pfizer, Icahn Enterprises, and Western Union, have been distributing dividends exceeding their net income and operating cash flow for multiple years. This practice often relies on borrowing, which is unsustainable long-term and signals potential dividend cuts ahead. Investors should carefully review cash flow statements to avoid high yields that mask financial weakness. The article highlights the importance of assessing dividend safety beyond yield alone, as continued payouts without sufficient earnings can lead to significant share price declines when cuts occur.

As of Oct 07, 2026 18:11 WIB, Pfizer (PFE) trades on Pluang at USD 27.68 with a 1-day gain of 0.71%. Despite the article's warning on unsustainable dividends, Pfizer's dividend yield remains high at 6.25%. Pluang data also shows a market cap of $156.74 billion and a typical hold time of 157 days, indicating steady investor interest.

More News (PFE)

Pfizer's strong Q3 and raised 2026 EPS guidance ease patent expiration fears, keeping it a Buy for investors.

Pfizer's strong Q3 and raised 2026 EPS guidance ease patent expiration fears, keeping it a Buy for investors.

Pfizer Inc. delivered strong Q3 results driven by its oncology portfolio, Eliquis, and tafamidis franchise, with Eliquis revenue growing 25.2% year-over-year to about $2.5 billion. Despite concerns about an upcoming patent expiration cycle lasting ar...

Company Fundamentals
Bullish
18 hours ago
Pfizer beats Q3 revenue estimates, raises 2026 guidance, and shows strong margin growth.

Pfizer beats Q3 revenue estimates, raises 2026 guidance, and shows strong margin growth.

Pfizer reported Q3 revenue of $16.58 billion, exceeding estimates by $700 million, driven by a 32% growth in launched and acquired products and an improved gross margin of about 77%. The company raised its full-year 2026 revenue guidance to $62 billi...

Analyst Insights
Bullish
1 day ago
Three overlooked dividend stocks now yield over 5%, offering strong income potential with varied risk profiles.

Three overlooked dividend stocks now yield over 5%, offering strong income potential with varied risk profiles.

Three dividend stocks in healthcare, telecom, and financials—Pfizer, Verizon, and OneMain Holdings—currently yield over 5%, attracting income investors seeking high payouts. Pfizer offers a 5.94% yield with growing drug franchises but has tight free ...

Market News
Neutral
1 day ago
Conagra cuts dividend by 50% amid cash flow struggles, signaling market warning on sustainability.

Conagra cuts dividend by 50% amid cash flow struggles, signaling market warning on sustainability.

Conagra Brands cut its quarterly dividend from $0.35 to $0.175 due to negative free cash flow and high leverage, reflecting financial stress. The stock has declined over 38% in five years, showing market skepticism about dividend sustainability witho...

Market News
Bearish
1 day ago
Anti-obesity drug market to hit $64.96B by 2035, led by Eli Lilly and Novo Nordisk with strong new drug launches.

Anti-obesity drug market to hit $64.96B by 2035, led by Eli Lilly and Novo Nordisk with strong new drug launches.

The global anti-obesity drugs market is projected to grow from USD 8.96 billion in 2026 to USD 64.96 billion by 2035, driven by a CAGR of 24.71%. Eli Lilly and Novo Nordisk dominate the market with blockbuster drugs like Mounjaro, Zepbound, and Wegov...

Bullish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App